Science ❯ Biotechnology ❯ Vaccine Development

Clinical Trials

mRNA Technology Phase 3 Trials Phase 3 Studies Phase II Trials Phase 1 Trials Safety Concerns H5N1 Vaccine mRNA Therapies Immunology mRNA Vaccines Safety Protocols Research Studies Regulatory Affairs mRNA Vaccine Trials

Membrane-Bound mRNA HIV Vaccine Elicits Neutralizing Antibodies in 80% of Participants

An unexpected rate of hives in participants has prompted vaccine tweaks ahead of larger trials.